What is the "political gimmick" you refer to?
CSL are producing one of the vaccines domestically - the Oxford-AstraZeneca vaccine. That's a known fact, not any gimmick.
CSL producing someone else's vaccine, like they are here, is nowhere near as profitable compared to producing their own vaccine, but that isn't happening now. I don't expect the current arrangements to have material bottom line impacts for CSL - based on what they have previously publicly announced.
